Heng Mei

机构：Union Hospital, Wuhan Union Hospital, Hubei Cancer Hospital, Union Hospital, Huazhong University of Science and Technology · ORCID：0000-0001-7941-2443

发表论文 332 篇 · 总被引 7982 次 · h-index 35

代表论文

• In vivo CAR cell therapy: from bench to bedside (2025 · Journal of Hematology & Oncology · 被引 15)
• Integrin αvβ8–mediated TGF-β1 activation regulates the sustained response in immune thrombocytopenia after TPO-RA withdrawal (2025 · Blood · 被引 4)
• Bone marrow blasts- and modified EASIX-guided risk stratification for coagulopathy and outcomes after CAR-T therapy in relapsed/refractory B-ALL (2025 · Thrombosis Research · 被引 2)
• Novel oral chidamide and valganciclovir regimen for EBV-PTLD post-hematopoietic stem cell transplantation: A case report (2026 · Medicine · 被引 1)
• Hetrombopag for patients with persistent primary immune thrombocytopenia: A post-hoc analysis of a multicenter, randomized phase Ⅲ Trial (2025 · Blood · 被引 1)
• CTD402, allogeneic anti-CD7 CAR t-cell, in relapsed or refractory (R/R) t-cell acute lymphoblastic leukemia/lymphoblastic lymphoma (T-ALL/LBL) - report of clinical outcomes at the recommended phase 2 dose (RP2D) (2025 · Blood · 被引 1)